Stefan Kol

Stefan Kol

Auto-generated profile, based on publicly available information

Stefan Kol

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2004 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
Martin Van Der LaanMartin Van Der Laan
Martin Van Der Laan
PBPhilipp Bechtluft
Philipp Bechtluft
SKStef Kol
Stef Kol
NNNico Nouwen
Nico Nouwen
ADArnold J.M. Driessen
Arnold J.M. Driessen
The Escherichia coli YidC protein belongs to the Oxa1 family of membrane proteins that have been suggested to facilitate the insertion and assembly of membrane proteins either in cooperation with the Sec translocase or as a separate entity. Recently, we have shown that depletion of YidC causes a specific defect in the functional assembly of F1F0 ATP synthase and cytochrome o oxidase. We now demonstrate that the insertion of in vitro–synthesized F1F0 ATP synthase subunit c (F0c) into inner membrane vesicles requires YidC. Insertion is independent of the proton motive force, and proteoliposomes containing only YidC catalyze the membrane insertion of F0c in its native transmembrane topology whereupon it assembles into large oligomers. Co-reconstituted SecYEG has no significant effect on the insertion efficiency. Remarkably, signal recognition particle and its membrane-bound receptor FtsY are not required for the membrane insertion of F0c. In conclusion, a novel membrane protein insertion pathway in E. coli is described in which YidC plays an exclusive role.

1 August 2010 in Microbiology
Verified
Journal Article
Open access
MGMarco Gottelt
Marco Gottelt
SKStefan Kol
Stefan Kol
JGJuan Pablo Gomez-Escribano
Juan Pablo Gomez-Escribano
MBMervyn Bibb
Mervyn Bibb
ETEriko Takano
Eriko Takano
Genome sequencing of Streptomyces coelicolor A3(2) revealed an uncharacterized type I polyketide synthase gene cluster (cpk). Here we describe the discovery of a novel antibacterial activity (abCPK) and a yellow-pigmented secondary metabolite (yCPK) after deleting a presumed pathway-specific regulatory gene (scbR2) that encodes a member of the γ-butyrolactone receptor family of proteins and which lies in the cpk gene cluster. Overproduction of yCPK and abCPK in a scbR2 deletion mutant, and the absence of the newly described compounds from cpk deletion mutants, suggest that they are products of the previously orphan cpk biosynthetic pathway in which abCPK is converted into the yellow pigment. Transcriptional analysis suggests that scbR2 may act in a negative feedback mechanism to eventually limit yCPK biosynthesis. The results described here represent a novel approach for the discovery of new, biologically active compounds.

28 November 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
TSTim Snoek
Tim Snoek
ECEvan K Chaberski
Evan K Chaberski
FAFrancesca Ambri
Francesca Ambri
SKStefan Kol
Stefan Kol
SBSara P Bjørn
Sara P Bjørn
JKJay D Keasling
Jay D Keasling
Allosteric transcription factors (aTFs) have proven widely applicable for biotechnology and synthetic biology as ligand-specific biosensors enabling real-time monitoring, selection and regulation of cellular metabolism. However, both the biosensor specificity and the correlation between ligand concentration and biosensor output signal, also known as the transfer function, often needs to be optimized before meeting application needs. Here, we present a versatile and high-throughput method to evolve prokaryotic aTF specificity and transfer functions in a eukaryote chassis, namely baker's yeast Saccharomyces cerevisiae. From a single round of mutagenesis of the effector-binding domain (EBD) coupled with various toggled selection regimes, we robustly select aTF variants of the cis,cis-muconic acid-inducible transcription factor BenM evolved for change in ligand specificity, increased dynamic output range, shifts in operational range, and a complete inversion-of-function from activation to repression. Importantly, by targeting only the EBD, the evolved biosensors display DNA-binding affinities similar to BenM, and are functional when ported back into a prokaryotic chassis. The developed platform technology thus leverages aTF evolvability for the development of new host-agnostic biosensors with user-defined small-molecule specificities and transfer functions.

10 April 2015 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
LGLise Marie Grav
Lise Marie Grav
Jae Seong LeeJae Seong Lee
Jae Seong Lee
SGSigne Gerling
Signe Gerling
TKThomas Beuchert Kallehauge
Thomas Beuchert Kallehauge
AHAnders Holmgaard Hansen
Anders Holmgaard Hansen
HKHelene Faustrup Kildegaard
Helene Faustrup Kildegaard

20 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKStefan Kol
Stefan Kol
DLDaniel Ley
Daniel Ley
TWTune Wulff
Tune Wulff
MDMarianne Decker
Marianne Decker
JAJohnny Arnsdorf
Johnny Arnsdorf
NLNathan Lewis
Nathan Lewis
Host cell proteins (HCPs) are process-related impurities generated during biotherapeutic protein production. HCPs can be problematic if they pose a significant metabolic demand, degrade product quality, or contaminate the final product. Here, we present an effort to create a “clean” Chinese hamster ovary (CHO) cell by disrupting multiple genes to eliminate HCPs. Using a model of CHO cell protein secretion, we predict that the elimination of unnecessary HCPs could have a non-negligible impact on protein production. We analyze the HCP content of 6-protein, 11-protein, and 14-protein knockout clones. These cell lines exhibit a substantial reduction in total HCP content (40%-70%). We also observe higher productivity and improved growth characteristics in specific clones. The reduced HCP content facilitates purification of a monoclonal antibody. Thus, substantial improvements can be made in protein titer and purity through large-scale HCP deletion, providing an avenue to increased quality and affordability of high-value biopharmaceuticals.

15 April 2010 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
SKStefan Kol
Stefan Kol
MMM. Elena Merlo
M. Elena Merlo
RSRichard A. Scheltema
Richard A. Scheltema
MVMarcel de Vries
Marcel de Vries
RVRoel J. Vonk
Roel J. Vonk
ETEriko Takano
Eriko Takano
The humicolous actinomycete Streptomyces coelicolor routinely adapts to a wide variety of habitats and rapidly changing environments. Upon salt stress, the organism is also known to increase the levels of various compatible solutes. Here we report the results of the first high-resolution metabolomics time series analysis of various strains of S. coelicolor exposed to salt stress: the wild type, mutants with progressive knockouts of the ectoine biosynthesis pathway, and two stress regulator mutants (with disruptions of the sigB and osaB genes). Samples were taken from cultures at 0, 4, 8, and 24 h after salt stress treatment and analyzed by liquid chromatography-mass spectrometry with an LTQ Orbitrap XL mass spectrometer. The results suggest that a large fraction of amino acids is upregulated in response to the salt stress, as are proline/glycine-containing di- and tripeptides. Additionally we found that 5′-methylthioadenosine, a known inhibitor of polyamine biosynthesis, is downregulated upon salt stress. Strikingly, no major differences between the wild-type cultures and the two stress regulator mutants were found, indicating a considerable robustness of the metabolomic response to salt stress, compared to the more volatile changes in transcript abundance reported earlier.